BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2020
View Archived Issues
Presepsin may have prognostic utility for the stratification of patients at risk of severe COVID-19
Read More
HSK-26784 shows efficacy in multiple B lymphocyte-derived malignancy models
Read More
Discovery of novel PRMT5 inhibitor, ALG-0700043
Read More
Initiator Pharma obtains U.K. approval to begin phase IIa study of IP-2018
Read More
Enspryng approved in Japan for adults and children with NMOSD
Read More
FDA grants IND allowance for phase Ia/b study of CG-806 in AML
Read More
Positive data from phase III RHAPSODY study of rilonacept in recurrent pericarditis
Read More
Fibroblast growth factor receptor 4 inhibitors described by Guangdong Newopp Biopharmaceuticals
Read More
Autobahn Therapeutics presents new thyroid hormone receptor beta agonists
Read More
Xeomin botulinum toxin type A receives marketing approval in Japan
Read More
Korea Research Institute of Chemical Technology patents PDE9A inhibitors
Read More
FDA clears IND for RP-L401 gene therapy for infantile malignant osteopetrosis
Read More
Roche discovers anti-hepatitis B virus compounds
Read More
Boehringer Ingelheim and Hydra Biosciences present new TrpC5 antagonists
Read More
First phase I data presented for HM-15136
Read More
Topline data reported from phase III SURE1 study of sulopenem
Read More
Janssen presents preclinical data for first-in-class MALT1 inhibitor JNJ-6785663
Read More
COVID-19: study points to kinases as HIV combo falls flat for SARS-CoV-2
Read More
Topline results presented from phase I/II study of ITI-214 heart failure
Read More
Onoact approved for additional indication of tachyarrhythmia associated with sepsis in Japan
Read More
Vadadustat approved in Japan for the treatment of anemia due to CKD
Read More
AOBiome begins phase IIb study with B-244 for pruritus in atopic dermatitis
Read More
Ongentys tablets approved in Japan for patients with PD with motor fluctuations
Read More
Phase II topline data reported for tisotumab vedotin in recurrent or metastatic cervical cancer
Read More
RedHill gains U.K. clearance to begin phase II/III trial of opaganib in severe COVID-19
Read More
FDA approves Keytruda for first-line unresectable or metastatic MSI-H or dMMR colorectal cancer
Read More
TFF reports clinical progress with inhalation powder formulations of tacrolimus and voriconazole
Read More
FDA issues complete response letter for Intercept's obeticholic acid for NASH fibrosis
Read More
FDA approves Phesgo for HER2-positive breast cancer
Read More
